Kersti Oselin is a medical oncologist with specialization on thoracic oncology. Main research interests include translational research of NSCLC recurrence, and development of artificial intelligence tool combining radiomics and genomics. In addition, she has interests in end of life care and health care resource use in advanced cancer patients. She completed her PhD on clinical pharmacology and pharmacogenetics of ADME. Also worked at the State Agency of Medicines in Estonia, and at the Medicines and Healthcare Products Regulatory Agency in the UK. During PhD studies, she was involved in research at the Institute of Pharmacology, University of Tartu, Estonia, and at the Institute of Clinical Pharmacology, University Medical Centre Charité, Humboldt University, Berlin. Currently, she works as medical oncologist at the North Estonia Medical Centre, Tallinn, largest cancer care provider in Estonia.